| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 42.274 | 259.286 |
| Total Income - EUR | - | - | - | - | - | - | - | 5.226 | 75.737 | 259.300 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 5.759 | 83.648 | 245.343 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -533 | -7.911 | 13.957 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -533 | -7.911 | 13.011 |
| Employees | - | - | - | - | - | - | - | 0 | 1 | 4 |
Check the financial reports for the company - Lisifarm Medicare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 5.269 | 44.550 | 43.750 |
| Current Assets | - | - | - | - | - | - | - | 8.392 | 38.280 | 102.183 |
| Inventories | - | - | - | - | - | - | - | 0 | 18.491 | 67.613 |
| Receivables | - | - | - | - | - | - | - | 642 | 18.315 | 21.034 |
| Cash | - | - | - | - | - | - | - | 7.750 | 1.474 | 13.537 |
| Shareholders Funds | - | - | - | - | - | - | - | -533 | -8.402 | 4.655 |
| Social Capital | - | - | - | - | - | - | - | 0 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 14.194 | 91.233 | 141.278 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Lisifarm Medicare S.r.l.